To evaluate tolerability and sex-related differences in the response of serum lipids to simvastatin administered in postmenopausal women and men with hypercholesterolemia.
S-POLIS (Saitama Postmenopausal Lipid Intervention Study)
18 Mar, 14
Sex-related differences in response of plasma lipids to simvastatin: the Saitama Postmenopausal Lipid Intervention Study.
Purpose
Design
Multicenter study
Patients
122 postmenopausal women and 55 men with serum total cholesterol levels -220 mg/dl.
Follow-up
12 months
Treatment Regimen
Simvastatin
Results
- Mean percentage changes in total cholesterol and LDL cholesterol levels in women (20% and 28%, respectively) were significantly greater than those in men (15% and 20%, respectively)
- There were no sex-related differences in the percentage changes in triglycerides or HDL cholesterol levels, although the changes were influenced by baseline levels
Conclusion
Simvastatin therapy for 12 months is well tolerated and effective for both women and men with hypercholesterolemia. Sex-related differences occurred in response to simvastatin therapy of serum lipids, especially total cholesterol and LDL cholesterol, with greater changes in lipid levels occurring in women.
Clin Ther 1999;21:2047-57






